Quality by design (QbD) approach in processing polymeric nanoparticles loading anticancer drugs by high pressure homogenizer

Polymeric nanoparticles prepared using high pressure homogenizer (HPH) present some unique challenges during manufacturing which can be better understood by application of quality by design (QbD) approaches. The present review highlights the ways to identify the critical material attributes which includes the anticancer drugs, polymers, surfactants, solvent system and dispersion system. A comprehensive understanding of the critical processing parameters like pressure and number of cycles during the working of HPH used in putting forward the critical quality attributes such as size, shape, surface charge or droplet stabilization. Such QbD approach will involve development of an effective control strategy for would ensure safe encapsulation of anticancer drugs for successful product development. Proper addressing of the issues related to scaling-up would lead to successful commercialization of the nano-sized formulations loaded with anticancer drugs.

[1]  Govind Soni,et al.  High encapsulation efficiency of poloxamer-based injectable thermoresponsive hydrogels of etoposide , 2014, Pharmaceutical development and technology.

[2]  Ruirui Xing,et al.  Carrier-Free, Chemophotodynamic Dual Nanodrugs via Self-Assembly for Synergistic Antitumor Therapy. , 2016, ACS applied materials & interfaces.

[3]  X. Xia,et al.  Effect of high-pressure homogenization preparation on mean globule size and large-diameter tail of oil-in-water injectable emulsions , 2015, Journal of food and drug analysis.

[4]  M. Gupta,et al.  QbD based approach for formulation development of spray dried microparticles of erlotinib hydrochloride for sustained release , 2020 .

[5]  Tamara L. Kinzer-Ursem,et al.  Physical characterization of nanoparticle size and surface modification using particle scattering diffusometry. , 2016, Biomicrofluidics.

[6]  K. Landfester,et al.  Surfactant Concentration Regime in Miniemulsion Polymerization for the Formation of MMA Nanodroplets by High-Pressure Homogenization , 2011, Langmuir : the ACS journal of surfaces and colloids.

[7]  A. Misra,et al.  Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability , 2017, BioMed research international.

[8]  J. Ulrich,et al.  High‐Pressure Homogenization as a Process for Emulsion Formation , 2004 .

[9]  R. Candal,et al.  Nanoemulsions: stability and physical properties , 2017 .

[10]  Jiandu Lei,et al.  Self-assembled pH-responsive polymeric nanoparticles based on lignin-histidine conjugate with small particle size for efficient delivery of anti-tumor drugs , 2020 .

[11]  Jun Fang,et al.  The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. , 2011, Advanced drug delivery reviews.

[12]  Yongchun Liu,et al.  High drug-loading nanomedicines: progress, current status, and prospects , 2017, International journal of nanomedicine.

[13]  H. Schuchmann,et al.  Extending Applications of High-Pressure Homogenization by Using Simultaneous Emulsification and Mixing (SEM)—An Overview , 2016 .

[14]  G. Amidon,et al.  Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue. , 2016, Journal of Pharmacy and Science.

[15]  Vasco Filipe,et al.  Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein Aggregates , 2010, Pharmaceutical Research.

[16]  S. Jafari,et al.  Re-coalescence of emulsion droplets during high-energy emulsification , 2008 .

[17]  Khushwant S Yadav,et al.  Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation. , 2010, Current drug delivery.

[18]  J. Kreuter,et al.  Toxicological study of doxorubicin‐loaded PLGA nanoparticles for the treatment of glioblastoma , 2019, International journal of pharmaceutics.

[19]  M. Abdollahi,et al.  Synthetic and biological identities of polymeric nanoparticles influencing the cellular delivery: An immunological link. , 2019, Journal of colloid and interface science.

[20]  M. Gorshkova,et al.  Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells. , 2017, International journal of pharmaceutics.

[21]  S. Satyanarayanajois,et al.  Concurrent delivery of tocotrienols and simvastatin by lipid nanoemulsions potentiates their antitumor activity against human mammary adenocarcenoma cells. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[22]  Meenakshi Malhotra,et al.  Human Serum Albumin Nanoparticles for Use in Cancer Drug Delivery: Process Optimization and In Vitro Characterization , 2016, Nanomaterials.

[23]  Tsuyoshi Murata,et al.  {m , 1934, ACML.

[24]  P. Maiti,et al.  Controlled drug delivery vehicles for cancer treatment and their performance , 2018, Signal Transduction and Targeted Therapy.

[25]  Anjali Jain,et al.  Biodegradable polymers for targeted delivery of anti-cancer drugs , 2016, Expert opinion on drug delivery.

[26]  P. Kantoff,et al.  Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.

[27]  K. Yadav,et al.  High Pressure Homogenizer in Pharmaceuticals: Understanding Its Critical Processing Parameters and Applications , 2020 .

[28]  L. Kumar,et al.  A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization , 2016, International journal of nanomedicine.

[29]  Qi Wang,et al.  Stabilization of water-in-octane nano-emulsion. Part I: Stabilized by mixed surfactant systems , 2010 .

[30]  Young-Joon Park,et al.  High paclitaxel-loaded and tumor cell-targeting hyaluronan-coated nanoemulsions. , 2017, Colloids and surfaces. B, Biointerfaces.

[31]  Eun Seong Lee,et al.  Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer. , 2015, International journal of pharmaceutics.

[32]  S. Rezaee,et al.  Oral delivery of indinavir using mPEG-PCL nanoparticles: preparation, optimization, cellular uptake, transport and pharmacokinetic evaluation , 2019, Artificial cells, nanomedicine, and biotechnology.

[33]  A. Ludwig,et al.  Influence of the homogenisation procedure on the physicochemical properties of PLGA nanoparticles. , 2004, Chemical & pharmaceutical bulletin.

[34]  P. Budd,et al.  Highly monodisperse, lanthanide-containing polystyrene nanoparticles as potential standard reference materials for environmental “nano” fate analysis , 2015 .

[35]  H. Schubert,et al.  Emulsification in High‐Pressure Homogenizers , 2001 .

[36]  Vincent M Rotello,et al.  Effect of nanoparticle surface charge at the plasma membrane and beyond. , 2010, Nano letters.

[37]  Muhammad Imran,et al.  PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution , 2019, Drug Delivery and Translational Research.

[38]  C. Dora,et al.  Novel Gemcitabine Conjugated Albumin Nanoparticles: a Potential Strategy to Enhance Drug Efficacy in Pancreatic Cancer Treatment , 2017, Pharmaceutical Research.

[39]  Mary E Napier,et al.  The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies. , 2010, Journal of the American Chemical Society.

[40]  S. Feng,et al.  Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy. , 2007, International journal of pharmaceutics.

[41]  G. Battogtokh,et al.  Self-assembled Chitosan-Ceramide Nanoparticle for Enhanced Oral Delivery of Paclitaxel , 2014, Pharmaceutical Research.

[42]  Teri W. Odom,et al.  Shape-Dependent Relaxivity of Nanoparticle-Based T1 Magnetic Resonance Imaging Contrast Agents. , 2016, The journal of physical chemistry. C, Nanomaterials and interfaces.

[43]  S. Mahajan,et al.  The Effect of Cage Shape on Nanoparticle-Based Drug Carriers: Anticancer Drug Release and Efficacy via Receptor Blockade Using Dextran-Coated Iron Oxide Nanocages. , 2016, Nano letters.

[44]  R. Murthy,et al.  Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles , 2007, AAPS PharmSciTech.

[45]  A. Rathore,et al.  Quality by design for biopharmaceuticals , 2009, Nature Biotechnology.

[46]  Y. Yeo,et al.  Surface Modification of Polymeric Nanoparticles with M2pep Peptide for Drug Delivery to Tumor-Associated Macrophages , 2019, Pharmaceutical Research.

[47]  Sun Young Min,et al.  Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[48]  Ying Zheng,et al.  Stability of nanosuspensions in drug delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[49]  K. Yadav,et al.  Communication of Drug Loaded Nanogels with Cancer Cell Receptors for Targeted Delivery , 2017 .

[50]  L. Kumar,et al.  Use of Nanoparticles in Medicine , 2020 .

[51]  P. Rai,et al.  Targeting Cancer using Polymeric Nanoparticle mediated Combination Chemotherapy , 2016, International journal of nanomedicine and nanosurgery.

[52]  M. Zandrahimi,et al.  PARTICLE SIZE CHARACTERIZATION OF NANOPARTICLES–A PRACTICALAPPROACH , 2011 .

[53]  M Ferrari,et al.  The adhesive strength of non-spherical particles mediated by specific interactions. , 2006, Biomaterials.

[54]  M. S. Muthu,et al.  Challenges posed by the scale-up of nanomedicines. , 2012, Nanomedicine.

[55]  Lei Miao,et al.  Development of etoposide-loaded bovine serum albumin nanosuspensions for parenteral delivery , 2015, Drug delivery.

[56]  Eun Seong Lee,et al.  Paclitaxel and curcumin co-bound albumin nanoparticles having antitumor potential to pancreatic cancer , 2016 .

[57]  Mauro Ferrari,et al.  Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.

[58]  Kwangmeyung Kim,et al.  Tumor-targeting glycol chitosan nanocarriers: overcoming the challenges posed by chemotherapeutics , 2019, Expert opinion on drug delivery.

[59]  C. Tan,et al.  Optimization of process parameters in preparation of tocotrienol-rich red palm oil-based nanoemulsion stabilized by Tween80-Span 80 using response surface methodology , 2018, PloS one.

[60]  K. Yadav,et al.  Long circulating nanoparticles of etoposide using PLGA‐MPEG and PLGA‐pluronic block copolymers: characterization, drug‐release, blood‐clearance, and biodistribution studies , 2010 .

[61]  J. Park,et al.  Recent Advances in Polymeric Nanomedicines for Cancer Immunotherapy , 2019, Advanced healthcare materials.

[62]  C. Dora,et al.  Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management. , 2018, Acta biomaterialia.

[63]  Eun Seong Lee,et al.  Doxorubicin and paclitaxel co-bound lactosylated albumin nanoparticles having targetability to hepatocellular carcinoma. , 2017, Colloids and surfaces. B, Biointerfaces.

[64]  K. Yadav,et al.  Design of Experiments (DoE) Approach to Optimize the Sustained Release Microparticles of Gefitinib. , 2019, Current drug delivery.

[65]  J. Doran,et al.  Does nanotechnology research generate an innovation premium over other types of research? Evidence from Ireland , 2019, Technology in Society.

[66]  Yan Li,et al.  Oral delivery of imatinib through galactosylated polymeric nanoparticles to explore the contribution of a saccharide ligand to absorption. , 2019, International journal of pharmaceutics.

[67]  H. Takeuchi,et al.  Effect of high-pressure homogenization on stability of emulsions containing zein and pectin , 2016, Asian journal of pharmaceutical sciences.

[68]  Qinglin Wu,et al.  The effect of chemical and high-pressure homogenization treatment conditions on the morphology of cellulose nanoparticles , 2014 .

[69]  S. Mitragotri,et al.  Role of nanoparticle size, shape and surface chemistry in oral drug delivery. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[70]  J. L. Santos,et al.  Shape Control in Engineering of Polymeric Nanoparticles for Therapeutic Delivery. , 2015, Biomaterials science.

[71]  C. Xie,et al.  An in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line , 2015, International journal of nanomedicine.

[72]  Neil Desai,et al.  Challenges in Development of Nanoparticle-Based Therapeutics , 2012, The AAPS Journal.

[73]  Warren C W Chan,et al.  The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.

[74]  Li Shi,et al.  Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers , 2010, Expert opinion on drug delivery.

[75]  Y. Zu,et al.  Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery , 2013, International journal of nanomedicine.

[76]  Chi‐Hwa Wang,et al.  Development of Nanoparticles for Drug Delivery to Brain Tumor: The Effect of Surface Materials on Penetration Into Brain Tissue. , 2019, Journal of pharmaceutical sciences.

[77]  Y. Liu,et al.  Size-dependent cellular uptake and localization profiles of silver nanoparticles , 2019, International journal of nanomedicine.

[78]  K. Yadav,et al.  Effect of Size on the Biodistribution and Blood Clearance of Etoposide-Loaded PLGA Nanoparticles. , 2011, PDA journal of pharmaceutical science and technology.

[79]  R. Goswami,et al.  Size-dependent cellular uptake and TLR4 attenuation by gold nanoparticles in lung adenocarcinoma cells. , 2019, Nanomedicine.